Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Hansoh Pharmaceutical Group, a China-based drug maker, pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares this week. -
Hansoh Pharmaceutical Group, a China-based drug maker, has pocketed HK$3.49bn ($450m) from a larger-than-planned issue of primary shares.
-
Singapore Airlines has announced the record date for its planned S$8.8bn ($6.17bn) concurrent rights issue and mandatory convertible bonds sale.
-
Aston Martin, the UK luxury car maker, has successfully completed its £371m heavily dilutive rights issue, with a high take-up from shareholders, including a consortium led by Canadian billionaire Lawrence Stroll.
-
Kotak Mahindra Bank’s board of directors will meet on Wednesday to determine the size and method for an equity capital fundraising plan that could be worth as much as $1bn.
-
English football’s highest level is at a clinch point as teams juggle a plunge in revenue, due to the suspension of the Premier League season, and the hefty overheads of player wages they must continue to pay. With clubs in need of cash, viable options are proving few and far between. Silas Brown, Sam Kerr and Mariam Meskin investigate.
